Zimiao Luo

1.4k total citations
20 papers, 1.2k citations indexed

About

Zimiao Luo is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Zimiao Luo has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 12 papers in Biomaterials and 11 papers in Molecular Biology. Recurrent topics in Zimiao Luo's work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (12 papers) and Extracellular vesicles in disease (5 papers). Zimiao Luo is often cited by papers focused on Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (12 papers) and Extracellular vesicles in disease (5 papers). Zimiao Luo collaborates with scholars based in China, South Korea and United States. Zimiao Luo's co-authors include Zhiqing Pang, Kai Jin, Bo Zhang, Ting Jiang, Wuli Yang, Peng Yang, Qin Jiang, Ranran Guo, Ye Tian and Haibao Peng and has published in prestigious journals such as Biomaterials, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Zimiao Luo

19 papers receiving 1.2k citations

Peers

Countries citing papers authored by Zimiao Luo

Since Specialization

Citations

This map shows the geographic impact of Zimiao Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zimiao Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zimiao Luo more than expected).

Fields of papers citing papers by Zimiao Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zimiao Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zimiao Luo. The network helps show where Zimiao Luo may publish in the future.

Co-authorship network of co-authors of Zimiao Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zimiao Luo. A scholar is included among the top collaborators of Zimiao Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zimiao Luo. Zimiao Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel long-acting C5a-blocking cyclic peptide prevents sepsis-induced organ dysfunction via effective blockade of the inflammatory cascade 2025 ·Signal Transduction and Targeted Therapy ·Zimiao Luo, Pengfei Luo, Haoyu Gu, Xiao Hu, Shichu Xiao, (unknown), Zhaofan Xia	0
2	All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment 2024 ·Journal of Controlled Release ·Yuan Ding, (unknown), Zhilan Chai, (unknown), (unknown), Jun Wang, Jianfen Zhou, Zimiao Luo, Yu Liu, Cao Xie, Linwei Lu, Weiyue Lu	19
3	Aptamer-Modified Erythrocyte Membrane-Coated pH-Sensitive Nanoparticles for c-Met-Targeted Therapy of Glioblastoma Multiforme 2022 ·Membranes ·Xianping Liu, Yixin Chen, (unknown), Haichun Li, Ting Jiang, Zimiao Luo, Jianhong Wang, Zhiqing Pang, Jun Zhang	13
4	All-stage targeted therapy for the brain metastasis from triple-negative breast cancer 2022 ·Acta Pharmaceutica Sinica B ·Zimiao Luo, (unknown), Jianfen Zhou, (unknown), (unknown), Linwei Lu, Cao Xie, Yu Liu, Weiyue Lu	16
5	In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy 2022 ·Journal of Controlled Release ·Zimiao Luo, Linwei Lu, (unknown), Nana Meng, (unknown), Jianfen Zhou, (unknown), Cao Xie, Yu Liu, Weiyue Lu	24
6	All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals 2022 ·Journal of Controlled Release ·(unknown), Linwei Lu, Jianfen Zhou, Danni Ran, Songli Wang, (unknown), (unknown), Jun Wang, Yu Liu, Cao Xie, Zimiao Luo, Weiyue Lu	33
7	Drug Nanocrystals for Active Tumor-Targeted Drug Delivery 2022 ·Pharmaceutics ·Linwei Lu, (unknown), (unknown), (unknown), Zimiao Luo, Weiyue Lu	35
8	Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting 2019 ·Beilstein Journal of Nanotechnology ·Xianping Liu, (unknown), Haichun Li, Ting Jiang, Zimiao Luo, Zhiqing Pang, (unknown), Jun Zhang	15
9	Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma 2018 ·Artificial Cells Nanomedicine and Biotechnology ·Ting Jiang, Bo Zhang, Long Zhang, Xuemei Wu, Haichun Li, Shun Shen, Zimiao Luo, Xianping Liu, Yu Hu, Zhiqing Pang, Xinguo Jiang	32
10	Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer 2018 ·Journal of drug targeting ·Bo Zhang, Honglan Wang, Ting Jiang, Kai Jin, Zimiao Luo, Wei Shi, Heng Mei, Huafang Wang, Yu Hu, Zhiqing Pang, Xinguo Jiang	22
11	On-Demand Drug Release from Dual-Targeting Small Nanoparticles Triggered by High-Intensity Focused Ultrasound Enhanced Glioblastoma-Targeting Therapy 2017 ·ACS Applied Materials & Interfaces ·Zimiao Luo, Kai Jin, Qiang Pang, Shun Shen, Zhiqiang Yan, Ting Jiang, Xiaoyan Zhu, Lei Yu, Zhiqing Pang, Xinguo Jiang	83
12	Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas 2017 ·ACS Applied Materials & Interfaces ·Ting Jiang, Bo Zhang, Shun Shen, (unknown), Zimiao Luo, Yu Hu, Zhiqing Pang, Xinguo Jiang	60
13	Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice 2017 ·Scientific Reports ·Bo Zhang, Kai Jin, Ting Jiang, (unknown), Shun Shen, Zimiao Luo, (unknown), Xianping Liu, Yu Hu, Zhiqing Pang	45
14	Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels 2017 ·Cancer Letters ·Bo Zhang, Ting Jiang, (unknown), Kai Jin, Zimiao Luo, Wei Shi, Heng Mei, Yu Hu, Zhiqing Pang, Xinguo Jiang	36
15	Biomimetic nanoparticles for inflammation targeting 2017 ·Acta Pharmaceutica Sinica B ·Kai Jin, Zimiao Luo, Bo Zhang, Zhiqing Pang	280
16	Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy 2017 ·Biomaterials ·Qin Jiang, Zimiao Luo, Yongzhi Men, Peng Yang, Haibao Peng, Ranran Guo, Ye Tian, Zhiqing Pang, Wuli Yang	295
17	BQ123 selectively improved tumor perfusion and enhanced nanomedicine delivery for glioblastomas treatment 2017 ·Pharmacological Research ·Bo Zhang, Honglan Wang, Kai Jin, Ting Jiang, Shun Shen, Zimiao Luo, (unknown), Xinguo Jiang, Xianping Liu, Yu Hu, Zhiqing Pang	4
18	Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion 2017 ·Biomaterials ·Xuejun Wang, Haichun Li, Xianping Liu, Ye Tian, Huishu Guo, Ting Jiang, Zimiao Luo, Kai Jin, Xinping Kuai, Yao Liu, Zhiqing Pang, Wuli Yang, Shun Shen	109
19	Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)–paclitaxel nanoconjugates 2016 ·Journal of Colloid and Interface Science ·Zimiao Luo, Zhiqiang Yan, Kai Jin, Qiang Pang, Ting Jiang, Heng Lu, Xianping Liu, Zhiqing Pang, Lei Yu, Xinguo Jiang	62
20	Effects of echinomycin on endothelin-2 expression and ovulation in immature rats primed with gonadotropins 2012 ·Experimental & Molecular Medicine ·Zhengchao Wang, Zhenghong Zhang, Yanqing Wu, Liyun Chen, (unknown), Jisen Zhang, (unknown), Zimiao Luo, Xiaohong Huang, Yong Cheng	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact